Use of Methacetin Breath Test to Predict Liver Failure in Patients With Cirrhosis
| Status: | Archived |
|---|---|
| Conditions: | Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | March 2010 |
| End Date: | March 2013 |
Use of the BreathID Methacetin Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Patients Awaiting Liver Transplantation
The methacetin breath test (MBT) is a non-invasive liver function test which measures the
ability of the liver to metabolize a tracer dose of a compound to carbon dioxide, which is
exhaled. The study hypothesis is that measurement of the MBT will allow earlier detection of
a decline in liver function in patients with cirrhosis who are awaiting liver
transplantation.
We found this trial at
3
sites
Virginia Commonwealth University Medical Center The Virginia Commonwealth University Health System is an urban, comprehensive...
Click here to add this to my saved trials
171 Ashley Avenue
Charleston, South Carolina 29425
Charleston, South Carolina 29425
843-792-1414
Medical University of South Carolina The Medical University of South Carolina (MUSC) has grown from...
Click here to add this to my saved trials
Henry Ford Hospital Founded in 1915 by auto pioneer Henry Ford and now one of...
Click here to add this to my saved trials